506172

p38 MAP Kinase Inhibitor X, BIRB 796

The p38 MAP Kinase Inhibitor X, BIRB 796, also referenced under CAS 285983-48-4, controls the biological activity of p38 MAP Kinase. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.

• 同義詞: p38 MAP Kinase Inhibitor X, BIRB 796, Doramapimod, BIRB796, 1-(5- tert-Butyl-2- p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)naphthalen-1-yl]urea, JNK Inhibitor XVII, Doramapimod, BIRB796, 1-(5-tert-Butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)naphthalen-1-yl]urea, JNK Inhibitor XVII
• 經驗公式（希爾表示法）: C₃₁H₃₇N₅O₃
• CAS號碼: 285983-48-4
• 分子量：: 527.66
• MDL號碼: MFCD09752957
• 分類程式碼代碼: 12352200
• NACRES: NA.77

屬性

• 品質等級: 100
• 化驗: ≥97% (HPLC)
• 形狀: solid
• 製造商／商標名: Calbiochem^®
• 儲存條件: OK to freeze; protect from light
• 顏色: white
• 溶解度: DMSO: 50 mg/mL, clear, colorless
• 運輸包裝: ambient
• 儲存溫度: 2-8°C
• SMILES 字串: CC1=CC=C(N2C(NC(NC3=CC=C(OCCN4CCOCC4)C5=C3C=CC=C5)=O)=CC(C(C)(C)C)=N2)C=C1
• InChI: 1S/C31H37N5O3/c1-22-9-11-23(12-10-22)36-29(21-28(34-36)31(2,3)4)33-30(37)32-26-13-14-27(25-8-6-5-7-24(25)26)39-20-17-35-15-18-38-19-16-35/h5-14,21H,15-20H2,1-4H3,(H2,32,33,37)
• InChI 密鑰: MVCOAUNKQVWQHZ-UHFFFAOYSA-N

描述

一般說明

A cell-permeable pyrazolo-napthalenyl urea compound that acts as a highly potent, slowly binding (IC₅₀ = 8 and 97 nM, respectively, against human p38α, respectively, with or without 2 h preincubation), but high affinity (t_1/2 of dissociation from human p38α = 23 h), p38-selective inhibitor by simultaneously targeting the ATP-binding site and an adjacent DFG-out conformation-specific allosteric cavity. It inhibits JNK2α2 and c-Raf-1 only at much higher concentrations (IC₅₀ = 98 nM and 1.4 µM, respectively) and displays little or no activity toward 10 other kinases (IC₅₀ >20 µM). Shown to inhibit LPS-induced TNF-α production both in vitro (IC₅₀ = 18 and 780 nM using THP-1 cells and in human whole blood, respectively) and in mice in vivo (by 84%; 30 mg/kg p.o.).

A cell-permeable pyrazolo-napthalenyl urea compound that acts as a highly potent, slowly binding (IC₅₀ = 8 and 97 nM, respectively, against human p38α, respectively, with or without 2 h preincubation), but high affinity (t_1/2 of dissociation from human p38α = 23 h), p38-selective inhibitor by simultaneously targeting the ATP-binding site and an adjacent DFG-out conformation-specific allosteric cavity. It inhibits JNK2α2 and c-Raf-1 only at much higher concentrations (IC₅₀ = 98 nM and 1.4 µM, respectively) and displays little or no activity toward 10 other kinases (IC₅₀ >20 µM). Shown to inhibit LPS-induced TNF-α production in cultures in vitro (IC₅₀ = 18 and 780 nM using THP-1 cells and in human whole blood, respectively) and in mice in vivo (by 84% and 63%, respectively, with oral dosage of 30 mg/kg and 10 mg/kg).

包裝

Packaged under inert gas

警告

Toxicity: Regulatory Review (Z)

重構

Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.

其他說明

Liu. Y. and Gray, N.S., 2006. Nat. Chem. Biol.2, 358.
Regan, J., et al. 2003. J. Med. Chem.46, 4676.
Pargellis, C., et al. 2002. Nat. Struct. Biol.9, 268.
Regan, J., et al. 2002. J. Med. Chem.45, 2994.

法律資訊

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

安全資訊

• 象形圖: GHS07
• 訊號詞: Warning
• 危險聲明: H302
• 防範說明: P264 - P270 - P301 + P312 - P501
• 危險分類: Acute Tox. 4 Oral
• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable